Boston: strong wind

Boston Scientific is loosing today, almost 3%, and this occurs, because of this news: The medical device maker Medtronic is planning three major product launches this year including an implanted device meant to be an early warning system for heart disease patients.

Another "nervous" point for investors is: For 2007, the company has concluded that forecasting the rate of growth in the cardiac rhythm management market and the drug-eluting stent market will be difficult, given the events and volatility in both markets during 2006. Since these two markets are so significant to the company's forecasted results of operations in 2007, the company believes it is appropriate to provide guidance only for the first quarter.

We still believe in Boston.